Grutsch et al. BMC Cancer 2011, 11:193 http://www.biomedcentral.com/1471-2407/11/193 Halberg F: Temporal coordination of physiologic function. Cold Spring Harb Symp Quant Biol 1960, 25:289-310. 2. Aschoff J: Circadian Rhythms In Man. Science 1965, 148:1427-32. 3. Lin JD, Liu C, Li S: Integration of energy metabolism and the mammalian clock. Cell Cycle 2008, 7:453-7. 4. Karatsoreos IN, Silver R: Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. Endocrinology 2007, 148:5640-7. 5. Panda S, Hogenesch JB, Kay SA: Circadian rhythms from flies to human. Nature 2002, 417:329-35. 6. Wever R: The circadian multi-oscillatory system of man. Int J Chronobiol 1975, 3:19-55. 7. Moore RY, Eichler VB: Central neural mechanisms in diurnal rhythm regulation and neuroendocrine responses to light. Psychoneuroendocrinology 1976, 1:265-79. 8. Souetre E, Salvati E, Belugou JL, et al: Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989, 28:263-78. 9. Foster RG, Roenneberg T: Human responses to the geophysical daily, annual and lunar cycles. Curr Biol 2008, 18:R784-R794. 10. Levin RD, Daehler MA, Grutsch JF, et al: Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 2005, 93:1202-8. 11. Rich T, Innominato PF, Boerner J, et al: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005, 11:1757-64. 12. Le Guen Y, Gagnadoux F, Hureaux J, et al: Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007, 58:139-43. 13. Hrushesky WHE, Lakatua D, Langevin T, Halberg F, Kennedy B: Marker rhythms for cancer chrono-chemotherapy. In Chronobiology Edited by: Haus E, Cabet H 1985, 493-499. 14. Mormont MC, Waterhouse J, Bleuzen P, et al: Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6:3038-45. 15. Iurisci I, Rich T, Levi F, et al: Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer. J Clin Oncol 2007, 25:e17-9. 16. Ancoli-Israel S, Liu L, Marler MR, et al: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006, 14:201-9. 17. Davidson JR, MacLean AW, Brundage MD, et al: Sleep disturbance in cancer patients. Soc Sci Med 2002, 54:1309-1321. 18. Mercadante S, Girelli D, Casuccio A: Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer 2004, 12:355-9. 19. Cleeland CS, Bennett GJ, Dantzer R, et al: Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine- immunologic model of cancer symptoms. Cancer 2003, 97:2919-25. 20. Mormont MC, Waterhouse J: Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int 2002, 19:313-23. 21. Walsh D, Rybicki L: Symptom clustering in advanced cancer. Support Care Cancer. 2006, 14:831-6. 22. Ferrans CE: Differences in what quality-of-life instruments measure. J Natl Cancer Inst Monogr 2007, 22-6. 23. Wilson IB, Cleary PD: Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care 1996, 34:610-23. 24. Sadeh A, Alster J, Urbach D, et al: Actigraphically based automatic bedtime sleep-wake scoring: validity and clinical applications. J of Ambulatory Monitoring 1989, 2:209-216. 25. Jean-Louis G, von Gizycki H, Zizi F, et al: Determination of sleep and wakefulness with the actigraph data analysis software (ADAS). Sleep 1996, 19:739-743. 26. Sadeh A, Sharkey KM, Carskadon MA: Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep 1994, 17:201-7. 27. Korszun A, Young EA, Engleberg NC, et al: Use of actigraphy for monitoring sleep and activity levels in patients with fibromyalgia and depression. J Psychosom Res 2002, 52:439-43. Page 12 of 13 28. Cole RJ, Kripke DF, Gruen W, et al: Automatic sleep/wake identification from wrist activity. Sleep 1992, 15:461-9. 29. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-76. 30. Bottomley A: The cancer patient and quality of life. Oncologist 2002, 7:120-5. 31. Ferrans CE: Definitions and conceptual models of quality of life. Cambridge, UK, Cambride University Press; 2005. 32. Scott NW, Fayers PM, Aaronson NK, et al: EORTC Reference Manual 2008. Brussels, Belgium, EORTC Quality of Life Group; 2008. 33. Hjermstad MJ, Fayers PM, Bjordal K, et al: Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ = C30 (+ 3). J Clin Oncol 1998, 16:1188-96. 34. Gupta D, Grutsch JF, Lis CG: Comparison of two quality of life instruments for cancer patients: the Ferrans and Powers Quality of Life Index and the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire C30. J Soc Integr Oncol 2008, 6:13-8. 35. Ancoli-Israel S, Cole R, Alessi C, et al: The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26:342-92. 36. Murphy F, Bentley S, Ellis BW, et al: Sleep deprivation in patients undergoing operation: a factor in the stress of surgery. Br Med J 1977, 2:1521-2. 37. Bentley S, Murphy F, Dudley H: Perceived noise in surgical wards and an intensive care area: an objective analysis. Br Med J 1977, 2:1503-6. 38. Salas RE, Gamaldo CE: Adverse effects of sleep deprivation in the ICU. Crit Care Clin 2008, 24:461-76, v-vi. 39. Hunter P: To sleep, perchance to live. Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep 2008, 9:1070-3. 40. Lin YM, Chang JH, Yeh KT, et al: Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinogensis 2008, 47:925-33. 41. Filipski E, King VM, Li X, et al: Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) 2003, 51:216-9. 42. Erren TC, Reiter RJ: Defining chronodisruption. J Pineal Res 2009, 46:245-7. 43. Penev PD, Kolker DE, Zee PC, et al: Chronic circadian desynchronization decreases the survival of animals with cardiomyopathic heart disease. Am J Physiol 1998, 275:H2334-7. 44. Ferrie JE, Shipley MJ, Cappuccio FP, et al: A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep 2007, 30:1659-66. 45. Sephton SE, Sapolsky RM, Kraemer HC, et al: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000, 92:994-1000. 46. Hrushesky WJ: Circadian timing of cancer chemotherapy. Science 1985, 228:73-5. 47. Rich TA: Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 2007, 5:167-74, discussion 176-7. 48. Mackiewicz M, Shockley KR, Romer MA, et al: Macromolecule biosynthesis: a key function of sleep. Physiol Genomics. 2007, 31:441-57. 49. Mystakidou K, Parpa E, Tsilika E, et al: The relationship of subjective sleep quality, pain, and quality of life in advanced cancer patients. Sleep 2007, 30:737-42. 50. Beck SL, Schwartz AL, Towsley G, et al: Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 2004, 27:140-8. 51. Nakamura T, Takumi T, Takano A, et al: Of mice and men–universality and breakdown of behavioral organization. PLoS One 2008, 3:e2050. 52. Bogdan A, Lellouch J, Misset J-L, et al: Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6:3038-45. 53. Berger AM, Farr LA, Kuhn BR, et al: Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007, 33:398-409. 54. Satlin A, Teicher MH, Lieberman HR, et al: Circadian locomotor activity rhythms in Alzheimer’s disease. Neuropsychopharmacology 1991, 5:115-26. 55. Ancoli-Isreal S, Clopton P, Klauber MR, et al: Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997, 20:24-27.